BFLY: Butterfly Network EV/EBITDA Multiple

Corporate emblem and logo of Butterfly Network (BFLY)

Slow adoption rates of portable scanners among physicians are weighing on Butterfly Network, Inc. (BFLY) revenues, forcing the business to optimize expenses. However, demand for affordable imaging remains steady, giving the sector defensive qualities even during an economic downturn. This chart on GURU.Markets with the value 0.00 illustrates the price action of the company, which develops AI-powered ultrasound systems for automated image interpretation.

Butterfly Corp - BFLY Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for butterflynetwork.com (BFLY)

- stock price and consensus target price:
Stock Quotes Butterfly iQ|BFLY - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Butterfly Corp|BFLY - Company Buyout Price
- issuer book value statistics:
Book Value per Share Butterfly Network|BFLY - Company Net Assets|Market Cap to Net Assets Ratio butterflynetwork.com|BFLY - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Butterfly Network, Inc.|BFLY - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Butterfly Network|BFLY - Company Cumulative Debt|Debts to Book Capitalization Butterfly Corp|BFLY - Company Long-Term Indebtedness|Company Short-Term Debts Butterfly Network|Quick Ratio butterflynetwork.com
- financial results and valuation multiples details:
BFLY - Net Income|Projected Future Earnings Butterfly Network, Inc.|BFLY - P/E Multiple|Future Price to Earnings Butterfly Network, Inc.|BFLY - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Butterfly Corp|BFLY - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Butterfly Network|BFLY - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months butterflynetwork.com|BFLY - Net earnings per share change in current year|Expected earnings per share growth for next year Butterfly Network, Inc.
Initial company analysis:Butterfly iQ BFLY
Original product of butterflynetwork.com

Butterfly Network, Inc. (BFLY) is scaling portable diagnostics through AI integration and strategic alliances with medtech firms. The EV/EBITDA multiple compares the total enterprise value, including debt, to operating profit before depreciation and amortization, determining the payback period for assets. Investors decouple fundamental value from market noise by analyzing the ratio of debt load to actual cash flow. The EV/EBITDA multiple trend captures the equilibrium points between market euphoria and the company's objective value.

Competitor analysis for Butterfly Network, Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)